Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis

Pediatr Infect Dis J. 2014 Jun;33(6):664-6. doi: 10.1097/INF.0000000000000260.

Abstract

After exposure to a teacher with multidrug-resistant pulmonary tuberculosis, 31 children developed latent infection. Twenty-six were treated with levofloxacin and pyrazinamide. Twelve required a change in therapy secondary to adverse effects. The most common adverse effects included abdominal pain, arthralgias/myalgias and elevated transaminases. All children reported at least 1 adverse effect. Fifteen children completed treatment. All adverse effects were transient.

MeSH terms

  • Adolescent
  • Antibiotic Prophylaxis / adverse effects
  • Antibiotic Prophylaxis / methods*
  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use*
  • Child
  • Contact Tracing
  • Humans
  • Latent Tuberculosis / drug therapy*
  • Latent Tuberculosis / epidemiology
  • Latent Tuberculosis / microbiology
  • Levofloxacin / adverse effects
  • Levofloxacin / therapeutic use
  • Pyrazinamide / adverse effects
  • Pyrazinamide / therapeutic use
  • Retrospective Studies
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / microbiology

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Levofloxacin